Corvus Pharmaceuticals Announces Partner Angel

BURLINGAME, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (NASDAQ: CRVS), a clinical-stage...

Related Keywords

China ,Yuqin ,Xizang ,United States ,Peking ,Beijing ,Chinese ,America ,American ,Angel Pharma ,Leiv Lea ,Richarda Miller ,Sheryl Seapy ,Angel Pharmaceuticals Ltd ,Exchange Commission On ,Corvus Pharmaceuticals ,Angel Pharmaceuticals ,Lymphoma Department At Peking University Cancer Hospital ,Lymphoma Alliance ,Corvus Pharmaceuticals Inc ,Exchange Commission ,American Society Of Hematology ,Company Quarterly Report On Form ,Chinese Society Of Clinical Oncology ,Angel Pharma Phase ,Song Yuqin ,Chinese Society ,Clinical Oncology ,Anti Lymphoma Alliance ,Deputy Director ,Lymphoma Department ,Peking University Cancer Hospital ,American Society ,Angel Pharmaceutical ,Quarterly Report ,Nasdaq Crvs ,Nc ,